http://www.aktiencheck.de aktiencheck.de aktiencheck.de Fri, 01 May 2026 10:35:07 +0200 2 http://www.aktiencheck.de/forum/Golden_Meditech_beobachten-722736-t294411 http://www.aktiencheck.de/forum/Golden_Meditech_beobachten-722736-t294411 Golden Meditech Started At Peer Perform - BS, Golden Meditech Started At Peer Perform - BS Bear Stearns starts coverage of Golden Meditech (8180.HK) at Peer Perform, end-2008 target of HK$4.30; notes it's largest supplier of Autologous Blood Recovery System (ABRS) used in hospital operating rooms, has China market share of more than 80%, according to company. Bear Stearns says: "As more ABRS are installed in hospitals in China, the sale of consumable chambers is beginning to make a meaningful contribution to sales and profit growth rates for this division." Notes company has good track record in new projects; has 9.9% stake in China Medical worth about US$100 million, 20X its initial investment. Says shares trading at fiscal 2008E P/E of 17.4X (excluding exceptional gains), estimates 26.2% forward EPS CAGR in fiscal 2008-2010E; DCF-based target price implies calendarized 2008E P/E of 17.6X vs peer group average of 23.5X. Shares last HK$3. [<a href="http://www.aktiencheck.de/forum/Golden_Meditech_beobachten-722736-t294411">mehr</a>]